New pyranoquinoline derivatives as vascular-disrupting anticancer agents
Crossref DOI link: https://doi.org/10.1007/s00044-019-02406-5
Published Online: 2019-07-27
Published Print: 2019-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schmitt, Florian
Schobert, Rainer
Biersack, Bernhard http://orcid.org/0000-0001-7305-346X
Text and Data Mining valid from 2019-07-27
Version of Record valid from 2019-07-27
Article History
Received: 14 March 2019
Accepted: 17 July 2019
First Online: 27 July 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.